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ABSTRACT 
The objective of the study was to review Pap test results and follow-ups in an urban sexually transmitted disease 
clinic in Miami, Florida. We reviewed the results of all Pap tests conducted in the clinic during 2005. All the 
samples were processed by a single commercial laboratory. We attempted to contact clients with abnormal results 
other than inflammation to return to the clinic. Results: of the 849 samples, 622 (73.3%) were normal, 211 (24.8%) 
were abnormal (inflammation 76 (9.0%), ASCUS 68 (8%), and LGSIL or higher 64 (7.5%), and 16 (1.9%) were 
considered unsatisfactory for cytological interpretation. We were able to contact only 57% of the clients that needed 
to return to the clinic. The rate of abnormal cervical cytology reported in this clinic in 2005 was well above the 
national average. A significant fraction, 43%, of clients who had abnormal results were unable to be contacted for 
follow-up. 
Florida Public Health Review, 2008; 5, 60-63. 
 
Introduction 
Cervical cancer, the most commonly diagnosed 
malignancy in women under 35 years of age in the 
United States (Boring, Squires, Tong, & 
Montgomery, 1994) is caused by human 
papillomavirus (HPV) infection, the most common 
sexually transmitted disease (STD) (Cates, 1999; 
Cogliano, Baan, Straif, Grosse, Secretan, & El 
Ghissassi, 2005; National Toxicology Program, 
2004). Cervical cytological screening using the 
Papanicolaou (Pap) test is widely accepted as a useful 
test for detection of cervical cancer and its 
precursors. The test has been credited as one of the 
factors associated with the dramatic decrease in the 
rates of cervical cancer in the United States. The 
mortality associated with cervical cancer has declined 
>70% since the inception of the Pap test and 
implementation of routine cervical cancer screening 
in most Western countries (National Institutes of 
Health, 1997). In the United States, invasive cervical 
cancer incidence decreased by 36% from 1973 to 
1991, accompanied by a 42% reduction in the age-
specific mortality rate (DiSaia & Creasman, 1993). 
Despite widespread availability of screening, 
women continue to develop cervical cancer. In the 
United States, 50% of cervical cancers occur in 
women who have never been screened, and 60% in 
women who have not been screened in the last 5 
years (Singleton & Orr, 1995 ). STD clinics have 
been considered important venues for Pap smear 
screening both because of the association of STD 
with cervical neoplasia and the fact that women 
attending such clinics often have poor preventive 
health-care seeking behavior and/or limited access to 
health services (Engelstad et al., 2001; Kamb, 1995). 
Pap tests, however, are not universally available at all 
public STD clinics in the United States.10  The overall 
rate of an abnormal cytology reported in the United 
States varies from 5% to 6%. Our objective was to 
review Pap test results and follow-ups in an urban 




The Miami-Dade County Health Department 
maintains four clinics dedicated to screening and 
treatment of sexually transmitted diseases. These 
clinics are strategically located in Miami-Dade 
County to meet the needs of communities most 
acutely in need of STD services. These clinics serve 
predominantly ethnic minorities and less than 25% of 
the clients have some type of third-party or health 
insurance coverage. In all these clinics Pap smear 
tests are routinely offered to all female patients who 
have not been tested for over one year. The study 
sample was drawn from patients of the Downtown 
Clinic (DTSTD), the busiest of the four clinics.  
Approximately 100 clients per day are seen, of which 
approximately 35% are women. 
  
Study Design 
We reviewed the results of all Pap tests 
performed in the DTSTD during 2005. Test results 
were evaluated using the 1991 revision to the 
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Bethesda scoring system for cervical cytology by a 
single commercial laboratory, in this case Laboratory 
Corporation of America. Results were classified as 
normal, inflammation, atypical cells of undetermined 
significance (ASCUS), low grade and high grade 
squamous intraepithelial lesions (LGSIL and 
HGSIL), and unsatisfactory samples. Clients with 
abnormal results other than inflammation were 
attempted to be contacted to return to the clinic or to 
receive a referral for specialized gynecological 
evaluation. Clients unable to be contacted were 
classified as “no returns.” Results were analyzed 
using descriptive statistics.  
 
Results 
From January to December 2005, a total of 849 
Pap tests were performed in the DTSTD. Of these 
849 samples, 622 (73.3%) were normal, 211 (24.8%) 
were abnormal, and 16 (1.9%) were considered 
unsatisfactory for cytological interpretation. In the 
total number of pap smears, inflammation 
represented 76 cases (9.0%); ASCUS, 68 cases 
(8.0%); LGSIL or higher, 64 cases (7.5%). In the 
analysis of the 211 pap smears that were not normal, 
76 (36%) were reported as inflammation, 68 (32.2%) 
ASCUS, 53 (25.1%) LGSIL, 11 (5.2%) HGSIL, and 
3 (1.4%) AGUS (Figure 1). Of the 227 patients that 
needed to be contacted to return to the clinic for 
further assessments, 57% returned and 43% were 
either unreachable or chose not to return. The age 
distribution of the total 849 Pap smear clients 
examined is shown in Table 1. Women from 20 to 44 




The findings of ASCUS rate of 8% and LGSIL 
or higher of 7.5% in our clinic are well above, up to 
three times, the rates found in the general population. 
However these rates are similar to the ones found in 
other STD clinics (Shlay, McGill, Masloboeva, & 
Douglas). We also found an inverse association 
between age and rates of cytological abnormalities 
(ASCUS or higher) where women 24 years of age or 
younger had two times or more rates of abnormalities 
than women older than 30 years of age, as shown in 
Table 1. These higher rates of cytological dysplasia 
seen in younger women have been well described 
(Centers for Disease Control and Prevention, 1994). 
Potential reasons for higher rates of cervical 
abnormalities in younger women are: early coitarche; 
more sexual partners; higher incidence of sexually 
transmitted infections; higher rate of smoking; and 
vulnerability of the adolescent cervix to the 
acquisition of sexually transmitted diseases and 
initiation of carcinogenesis (Moscicki, Winkler, 
Irwin, & Schachter, 1989; Shew, Fortenberry, & 
Amortegui, 1994). On the other hand, despite the 
expected high prevalence of STDs in the clinic, there 
was a reasonably low prevalence of inflammation 
(9.0%).  Finally, the rate of unsatisfactory smears in 
our clinic (1.9%) was above the target rates reported 
by the College of American Pathologists (0.5-1.0%), 
(Tauchi-Nishi, Gajda, & Nakimi, 1991) but lower 
than other STD clinics (3-3.5%) (Campbell, Hewitt, 
Kowalchuck, Joffres, & Romanowski, 1994; Shlay et 
al., 1998). 
The low follow-up care rate we found (57%) is 
similar to reported rates in similar settings such as 
urgent care centers and emergency departments.  
Low follow-up rates are probably related, in part, to 
the disruption in the continuity of care between the 
site of screening and the site of diagnostic and 
treatment services (Dunn, Jazbec, Awad, & Batal, 
2005; Engelstad et al., 2001). To address this 
problem there is a need to develop new methods for 
delivering continuity of care in this setting and 
implementing potential interventions. 
In conclusion, we found high rates of cytological 
abnormalities in this clinic, up to three times the 
national average. This finding in a setting where the 
majority of population have limited access to 
preventive health services, support the  incorporation 
of Pap smear screening into the standard of care for 
STD clinical practice. It also highlights the need of 
creative strategies to increase follow-up rates of 
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Table 1.  Pap Smears - Results by Age 
 







15 – 19 
 
96 11.3% 71 (73.9%) 24 (25%) 
20 – 24 
 
245 28.9% 184 (75%) 59 (24.1%) 
25 – 29 
 
124 14.6% 105 (84.7%) 16 (12.3%) 
30 – 34 
 
114 13.4% 99 (86.8%) 11 (9.6%) 
35 – 39 
 
95 11.2% 82 (86.3%) 10 (10.5%) 
40 – 44 
 
89 10.5% 77 (86.5%) 10 (11.2%) 
45 – 49 
 
50 5.9% 45 (90%) 4 (0.08%) 
 > 50  
 
36 4.2% 35 (97.2%) 1 (2.8%) 
Total 
 
849 99.9% 698 135 
*Percentage of subjects in age range to the total number. 
** Number of subjects with normal Pap+ inflammation result per age interval. Percentage per each age interval. 
***  Number of subjects with ASCUS or higher score (LGSIL, HGSIL) in each age interval. Percentage of ASCUS or higher 




Boring, C.C., Squires, T.S., Tong, T., & 
Montgomery, S. (1994). Cancer statistics. CA - A 
Cancer Journal for Clinicians, 44, 7-26. 
Campbell, P.J., Hewitt, S.H., Kowalchuck, P.A., 
Joffres, M., & Romanowski, B. (1994). Relationship 
of cervical cytologies to selected variables among 
women attending a sexually transmitted disease 
clinic. International Journal of STD & AIDS, 5, 108-
112. 
Cates,. W., Jr. (1999).  Estimates of the 
incidence and prevalence of sexually transmitted 
diseases in the United States. American Social Health 
Association Panel. Sexually Transmitted Diseases, 
26, S2-S7. 
Centers for Disease Control and Prevention. 
(1993). Results from the national breast and cervical 
cancer early detection program, October 1, 1991- 
September 30, 1993. Morbidity & Mortality Weekly 
Report, 43(29), 530-534. 
Cogliano, V., Baan, R., Straif, K., Grosse, Y., 
Secretan, B., & El Ghissassi, F. (2005). 
Carcinogenicity of human papillomaviruses. Lancet 
Oncology, 6, 204. 
DiSaia, P., & Creasman, W. (1993). Invasive 
cervical cancer: In: Clinical Gynecologic Oncology,  
4th ed. St. Louis, MO: Mosby Year Book, pp. 58-125. 
 
 
Dunn, T.S., Jazbec, A., Awad, R., & Batal, H.  
(2005). Papanicolaou screening in an urgent care 
setting. American Journal of Obstetrics and 
Gynecology, 192(4), 1084-6. 
Engelstad, L., Steward, S., Nguyen, B., et al. 
(2001). Abnormal Pap smear follow-up in a high risk 
population. Cancer Epidemiology, Biomarkers, & 
Prevention, 10, 1015-1020. 
Kamb, M. (1995). Cervical cancer screening of 
women attending sexually transmitted diseases 
clinics. Clinical Infectious Diseases, 20. S98-S103. 
Moscicki, A.B., Winkler, B., Irwin, C., & 
Schachter, J. (1989). Difference in biologic 
maturation, sexual behavior, and sexually transmitted 
diseases between adolescents with and without 
cervical intraepithelial neoplasia. Journal of 
Pediatrics, 115, 487-493. 
National Institutes of Health. (1997). Summary 
of the NIH Consensus Development Conference on 
Cervical Cancer. Oncology, 11(5), 672-674. 
National Toxicology Program. (2004). Annual 
report on carcinogens. 11th ed. Washington, D.C.: 
U.S. Department of Health and Human Services, 
Public Health Service. 
Shew, M.L., Fortenberry, J.D., & Amortegui, 
A.J. (1994).  Interval between menarche and first 
sexual intercourse, related to risk of human papilloma 
virus infection. Journal of Pediatrics, 125, 661-666. 
3
et al.: Papanicolaou Test in an Urban STD Clinic: The Good and Bad News
Published by UNF Digital Commons, 2008




Shlay, J., McGill, W., Masloboeva, H., & 
Douglas, J. (1998). Pap smear screening in an urban 
STD clinic: yield of screening and predictors of 
abnormalities. Sexually Transmitted Diseases, 25(9), 
468-475. 
Singleton, H., & Orr, J. (1995). Screening in 
Cancer of the Cervix. Philadelphia, PA, Lippincott-
Raven.  
Tauchi-Nishi, P.S., Gajda, R., & Nakimi, T.S. 
(1991). Quality assurance report for improving 
specimen adequacy in gynecologic cytology. CAP  
Today, 5, 12. 
 
 
José G. Castro (JCastro2@med.miami.edu), Araceli  Moneda 
(Araceli_moneda@doh.state.fl.us), and  Inza Patton 
(Inza_patton@doh.state.fl.us) are with the Department of 
Medicine, Division of Infectious Diseases, University of Miami 
Miller School  of Medicine and Miami-Dade County Health 
Department, Miami, FL. Giovanna  Baldarrago 
(Baldarragow@belldouth.net) is with Jackson Memorial Hospital, 
Miami, FL. This paper was submitted to the FPHR on April 24, 
2008, revised and resubmitted, and accepted for publication on 




Florida Public Health Review, Vol. 5 [2008], Art. 9
https://digitalcommons.unf.edu/fphr/vol5/iss1/9
